JP2010508349A - ジプテリニルカルシウム五水和物（ｄｃｐ）およびそれに基づく治療法 - Google Patents

ジプテリニルカルシウム五水和物（ｄｃｐ）およびそれに基づく治療法 Download PDF

Info

Publication number
JP2010508349A
JP2010508349A JP2009535306A JP2009535306A JP2010508349A JP 2010508349 A JP2010508349 A JP 2010508349A JP 2009535306 A JP2009535306 A JP 2009535306A JP 2009535306 A JP2009535306 A JP 2009535306A JP 2010508349 A JP2010508349 A JP 2010508349A
Authority
JP
Japan
Prior art keywords
dcp
administering
effective amount
subject
modulating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009535306A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010508349A5 (https=
Inventor
モヘノ，フィリップ
フレイデラー，ウォルフガング
Original Assignee
サンアールエックス ファーマスーティカルズ，インク．
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by サンアールエックス ファーマスーティカルズ，インク． filed Critical サンアールエックス ファーマスーティカルズ，インク．
Publication of JP2010508349A publication Critical patent/JP2010508349A/ja
Publication of JP2010508349A5 publication Critical patent/JP2010508349A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
JP2009535306A 2006-10-30 2007-10-30 ジプテリニルカルシウム五水和物（ｄｃｐ）およびそれに基づく治療法 Pending JP2010508349A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86354706P 2006-10-30 2006-10-30
PCT/US2007/023012 WO2008054793A2 (en) 2006-10-30 2007-10-30 Dipterinyl calcium pentahydrate (dcp) and therapeutic methods based thereon

Publications (2)

Publication Number Publication Date
JP2010508349A true JP2010508349A (ja) 2010-03-18
JP2010508349A5 JP2010508349A5 (https=) 2010-11-11

Family

ID=39344907

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009535306A Pending JP2010508349A (ja) 2006-10-30 2007-10-30 ジプテリニルカルシウム五水和物（ｄｃｐ）およびそれに基づく治療法

Country Status (7)

Country Link
US (2) US7662820B2 (https=)
EP (1) EP2094715B1 (https=)
JP (1) JP2010508349A (https=)
CN (1) CN101663308A (https=)
CA (1) CA2668262A1 (https=)
ES (1) ES2394227T3 (https=)
WO (1) WO2008054793A2 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2295061A1 (en) * 2002-08-22 2011-03-16 Dainippon Sumitomo Pharma Co., Ltd. Agent for treatment of schizophrenia
CN1826338B (zh) 2003-06-23 2011-07-13 大日本住友制药株式会社 老年性痴呆症治疗药
JP4847320B2 (ja) * 2004-02-20 2011-12-28 大日本住友製薬株式会社 統合失調症の記憶・学習機能障害治療薬のｉｎｖｉｖｏスクリーニング方法
CA2655933C (en) * 2006-06-23 2014-09-09 Alethia Biotherapeutics Inc. Polynucleotides and polypeptide sequences involved in cancer
US7662820B2 (en) * 2006-10-30 2010-02-16 Sanrx Pharmaceuticals, Inc. Dipterinyl calcium pentahydrate (DCP) and therapeutic methods based thereon
EP2276489A2 (en) * 2008-01-18 2011-01-26 Sanrx Pharmaceuticals, Inc. Pterin based therapies for inflammatory conditions
KR20110084280A (ko) 2008-11-03 2011-07-21 알레시아 바이오쎄라퓨틱스 인코포레이티드 종양 항원의 생물 활성을 특이적으로 차단하는 항체
US8258139B2 (en) 2010-11-08 2012-09-04 Dainippon Sumitomo Pharma Co., Ltd. Method of treatment for mental disorders
RS59080B1 (sr) 2011-03-31 2019-09-30 Adc Therapeutics Sa Antitela protiv antigena 1 povezanog sa bubrezima i njihovi fragmenti koji se vezuju za antigen
HRP20190946T1 (hr) 2012-01-09 2019-07-26 Adc Therapeutics Sa Sredstva za liječenje trostruko negativnog raka dojke
US20150010509A1 (en) * 2012-01-30 2015-01-08 Sanrx Pharmaceuticals, Inc. Calcium folate (cafolate) and therapeutic methods based thereon
CN104788300B (zh) * 2014-01-22 2017-01-11 南京华威医药科技开发有限公司 欧司哌米芬多晶型

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002527518A (ja) * 1998-10-22 2002-08-27 フィリップ・ビー・ビー・モヘノ 新規なプテリン抗新生物薬

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU757896B2 (en) 1998-09-02 2003-03-13 Allergan, Inc. Preserved cyclodextrin-containing compositions
DE19944767A1 (de) * 1999-09-17 2001-03-29 Vasopharm Biotech Gmbh & Co Kg N-substituierte 4-Aminopteridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US7662820B2 (en) * 2006-10-30 2010-02-16 Sanrx Pharmaceuticals, Inc. Dipterinyl calcium pentahydrate (DCP) and therapeutic methods based thereon

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002527518A (ja) * 1998-10-22 2002-08-27 フィリップ・ビー・ビー・モヘノ 新規なプテリン抗新生物薬

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JPN6013003429; Ｍｏｌ．　Ｃｒｙｓｔ．　Ｌｉｑ．　Ｃｒｙｓｔ． Ｖｏｌ．２７６, 1996, Ｐ．２２９-２３５ *
JPN6013003430; Ｉｎｏｒｇ．　Ｃｈｅｍ． Ｖｏｌ．３４, 1995, Ｐ．３３６７-３３７０ *

Also Published As

Publication number Publication date
ES2394227T3 (es) 2013-01-23
EP2094715A4 (en) 2010-04-28
US20100105692A1 (en) 2010-04-29
EP2094715A2 (en) 2009-09-02
CA2668262A1 (en) 2008-05-08
WO2008054793A3 (en) 2008-08-28
CN101663308A (zh) 2010-03-03
EP2094715B1 (en) 2012-08-29
US20080166355A1 (en) 2008-07-10
WO2008054793A2 (en) 2008-05-08
US7662820B2 (en) 2010-02-16

Similar Documents

Publication Publication Date Title
JP2010508349A (ja) ジプテリニルカルシウム五水和物（ｄｃｐ）およびそれに基づく治療法
BR112020017090A2 (pt) Imunoterapias relacionadas com microbioma
CN101360495B (zh) 对癌症病人给药mTOR抑制剂
WO2015161762A1 (zh) 环二核苷酸cGAMP在抗肿瘤中的应用
TW201513864A (zh) 含低用量伊立替康鹽酸鹽水合物之抗腫瘤劑
CN112272552A (zh) 包含糖皮质激素受体拮抗剂的固体形式和制剂及其用途
KR20190047628A (ko) 다공성 자성 나노입자 기반 약물 전달체 및 그 제조방법
CN101429201A (zh) 柠檬酸小檗胺盐及制备方法和应用
JPWO2010110223A1 (ja) 抗腫瘍作用を有するフコイダン
TW201728328A (zh) 針對具有重度腎功能障礙之癌症患者之治療方法
CN116271090B (zh) 一种具有tlr9激动剂活性的dna纳米笼及其在制备抗肿瘤药物中的应用
WO1992004028A1 (en) Antineoplastic effect potentiator and antineoplastic agent
CN114939122B (zh) 天然植物来源的联合抗肿瘤药物组合物
CN105078944A (zh) Isopaucifloral F在制备抗骨质疏松药物中的用途
CN104434948B (zh) 一种抗胰腺癌的药物组合物及其应用
CN113993515B (zh) 使用藏红花酸治疗实体肿瘤的方法
CN102451183B (zh) 一种孕甾双烯醇酮类化合物在制备抗肿瘤药物中的应用
US20170087125A1 (en) Flavonoid compositions for the treatment of cancer
HK1139952A (en) Dipterinyl calcium pentahydrate (dcp) and therapeutic methods based thereon
RU2015152096A (ru) Средство (варианты) и способы восстановления микрофлоры
JPWO2015152407A1 (ja) 抗腫瘍性白金錯体を含有する抗腫瘍剤及び抗腫瘍効果増強剤
JP4512322B2 (ja) 癌転移抑制剤
JP4825957B2 (ja) 抗腫瘍剤
CN102626426B (zh) 抗肿瘤复方茯苓素制剂及其制备方法
TW202245780A (zh) 用於治療神經膠質母細胞瘤之方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100916

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100916

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130129

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20130702